KRTAP19-2: A Potential Drug Target and Biomarker (G337969)

Target Name: KRTAP19-2

NCBI ID: G337969

KRTAP19-2

Other Name(s): KR192_HUMAN | Keratin-associated protein 19-2 | Keratin associated protein 19-2 | KAP19.2 | keratin associated protein 19-2

KRTAP19-2: A Potential Drug Target and Biomarker

KRTAP19-2 (KR192_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, and kidneys. It is a member of the KRTAP family, which is known for its role in intracellular signaling pathways.

One of the unique aspects of KRTAP19-2 is its expression pattern in different tissues. While it is typically expressed in the brain, heart, and kidneys, it is also found in other organs and tissues, such as the liver, pancreas, and cervical uterus. This makes it a potential drug target that could be effective in treating a range of diseases.

KRTAP19-2 has been shown to play a role in several biological processes that are important for human health. For example, it has been shown to be involved in the regulation of inflammation, cell signaling, and neurotransmitter release. It has also been shown to play a role in the development and progression of certain diseases, such as diabetes, heart disease, and neurodegenerative disorders.

One of the potential benefits of targeting KRTAP19-2 as a drug target is its potential to treat a wide range of diseases. Because it is involved in so many different biological processes, it could be effective in treating a variety of conditions that are currently untreated or have limited treatment options. For example, KRTAP19-2 has been shown to be involved in the regulation of inflammation, which could make it an effective target for treatments for autoimmune diseases such as rheumatoid arthritis, lupus, and multiple sclerosis.

In addition to its potential as a drug target, KRTAP19-2 has also been shown to be a useful biomarker for several diseases. Its expression has been shown to be associated with a range of diseases, including neurodegenerative disorders, cancer, and cardiovascular disease. This makes it a potential indicator of disease status and could be used as a diagnostic tool in some cases.

One of the challenges in studying KRTAP19-2 as a drug target is its complex structure and function. Because it is a protein that is expressed in many different tissues, it is difficult to study its effects in isolation. Additionally, the precise mechanisms by which KRTAP19-2 functions are not well understood, which can make it difficult to predict its effects as a drug.

Despite these challenges, researchers are actively working to study KRTAP19-2 as a drug target and to develop treatments that can effectively target its activity. Some researchers are using techniques such as small molecule inhibitors and RNA interference to study its functions and to identify potential drug targets. Others are using techniques such as live cell imaging and biochemical assays to study its interactions with other proteins and to understand its mechanisms of action.

In addition to its potential as a drug target and biomarker, KRTAP19-2 is also of interest to researchers as a potential therapeutic target for other diseases. Its expression has been shown to be involved in the regulation of a wide range of biological processes, including inflammation, cell signaling, and neurotransmission. This makes it a potential target for treatments for a variety of diseases, including neurodegenerative disorders, cancer, and cardiovascular disease.

Overall, KRTAP19-2 is a protein that has significant potential as a drug target and biomarker. Its complex structure and function make it difficult to study, but researchers are actively working to overcome these challenges and to develop effective treatments that can target its activity. Further research is needed to fully understand its mechanisms of action and to develop treatments that can effectively target its activity.

Protein Name: Keratin Associated Protein 19-2

Functions: In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins

The "KRTAP19-2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRTAP19-2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets